Arcturus therapeutics to advance arct-032, an aerosolized lunar® mrna-based therapeutic, as a development candidate for cystic fibrosis lung disease

San diego--(business wire)---- $arct #cftr--arcturus therapeutics to advance arct-032, an aerosolized lunar® mrna-based therapeutic, as a development candidate for cystic fibrosis lung disease
ARCT Ratings Summary
ARCT Quant Ranking